Assesses stiff person syndrome severity using STIFF scale, anti-GAD65 antibody titer, co-existing type 1 DM and cerebellar ataxia features, and baclofen/diazepam dosing adequacy for muscle rigidity control.
Assesses stiff person syndrome severity using STIFF scale, anti-GAD65 antibody titer, co-existing type 1 DM and cerebellar ataxia features, and baclofen/diazepam dosing adequacy for muscle rigidity control
Each component has a specific meaning:
Note: Interpret the sps severity score result against the thresholds and context described above.
Enter the STIFF scale, anti-GAD65 antibody titer, co-existing type 1 DM, cerebellar ataxia features, baclofen/diazepam dosing adequacy for the scenario you are assessing. Assesses stiff person syndrome severity using STIFF scale, anti-GAD65 antibody titer, co-existing type 1 DM and cerebellar ataxia features, and baclofen/diazepam dosing adequacy for muscle rigidity control. Use the sps severity score result to inform your calculation.